MedPath

Pericapsular Nerve Block Versus Propofol During Hip Fractures Surgery

Not Applicable
Not yet recruiting
Conditions
Difference in Reduction in Visual Analogue Score at 30 Minutes
Interventions
Procedure: pericapsular nerve group block for group A,low dose intravenous Propofol [0.7mg/kg] over 30 seconds for group B
Registration Number
NCT06631118
Lead Sponsor
Ain Shams University
Brief Summary

The study will compare the efficacy of Pericapsular nerve group block (PENG) versus low dose Propofol for the achievement of painless sitting position before spinal anesthesia in patients undergoing repair of Hip fractures.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • All patients in the age group ranging 40-70, both genders, belonging to physical status American Society of Anaesthesiologists (ASA) I and II
Read More
Exclusion Criteria
  • Patients with old fractures (more than 7 days), polytrauma, bleeding disorders or coagulopathy, local site infection, difficulty expressing pain scores such as hearing disability, mentally challenged, dementia or psychiatric illness and who refused to take part
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group Apericapsular nerve group block for group A,low dose intravenous Propofol [0.7mg/kg] over 30 seconds for group BGroup (A ) : will receive ultrasound guided pericapsular nerve group block (PENG) followed by spinal anesthesia.
Group Bpericapsular nerve group block for group A,low dose intravenous Propofol [0.7mg/kg] over 30 seconds for group BGroup B will receive low dose intravenous Propofol \[0.7mg/kg\] over 30 seconds followed by spinal anesthesia and so far, this is the most common and standard technique to achieve sitting position during spinal anesthesia for patients with hip fractures.
Primary Outcome Measures
NameTimeMethod
The difference in VAS scale30 min after giving propofol and the PENG block.

The primary outcome will be difference in median reduction in VAS-D .

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath